Skip to main content
EMA Logo
  • Medicines
    Medicines

    • Search
    • Download
    • What we publish and when
    • Medicines under evaluation
    • National registers
    • Medicines for use outside the EU
  • Human regulatory
    Human regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
    • Herbal products
  • Veterinary regulatory
  • Committees
    Committees

    • How the committees work
    • CHMP
    • CVMP
    • PRAC
    • COMP
    • HMPC
    • CAT
    • PDCO
    • Working parties and other groups
  • News & events
    News & events

    • News and press releases
    • Events
    • What's new
    • Committee highlights
    • Therapeutic areas: latest updates
    • Publications
    • Press and social media
    • Open consultations
    • RSS feeds
  • Partners & networks
    Partners & networks

    • EU partners
    • International activities
    • Patients and consumers
    • Healthcare professionals
    • Academia
    • Pharmaceutical industry
    • Networks
    • Health technology assessment bodies
  • About us
    About us

    • What we do
    • Who we are
    • How we work
    • Annual reports and work programmes
    • History of EMA
    • Careers
    • Procurement
    • Support to research
    • Contact
    • Legal
    • Glossary
    • Search tips
    • FAQs
    • Brexit: UK withdrawal from EU
Veterinary regulatory

  • Overview
  • Research and development
  • Marketing authorisation
  • Post-authorisation
  • Availability of veterinary medicines
  • Certificates for products
  • Compliance
  • Parallel distribution
  • Pharmacovigilance
  • Post-authorisation procedural Q&A
  • Referral procedures
  • Variations
    • Article 5 procedure
    • Type IA variations
    • Type IB variations
    • Type II variations
    • Grouping of variations
    • Worksharing of variations

Variations

A variation is a change to the terms of a marketing authorisation. This section provides guidance for marketing authorisation holders on the regulatory requirements and procedures for the different types of variations.

In this section

  • Article 5 procedure
  • Grouping of variations
  • Type IA variations
  • Type IB variations
  • Type II variations
  • Worksharing of variations

Related content

  • Post-authorisation

Related EU legislation

  • Commission Regulation (EC) No 1234/2008 ('the Variations Regulation')
  • Commission Regulation (EU) No 712/2012 of 3 August 2012 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products
  • Rules governing medicinal products in the European Union, volume 6, Notice to Applicants

Related documents

  • Procedural guidance on the handling of variations and on worksharing

How useful was this page?

Add your rating
Product emergency hotline
outside working hours
About
  • Who we are
  • Human regulatory
  • Veterinary regulatory
  • Committees
Ask EMA
  • Send a question
  • FAQs
  • Access to documents
Links
  • Legal
  • Privacy
  • Complaints
  • Contacts
  • Glossary
  • Search tips
  • Business hours and holidays
Contact

European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
The Netherlands

Tel: +31 (0)88 781 6000

For delivery address, see:
How to find us

The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. EMA is in the process of making appropriate changes to this website. If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network
European Union agencies network
An agency of the European Union
European Union flag